Pegylated interferon alpha-2b plus ribav
✍
Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 251 KB
👁 2 views
In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated